This study is testing a new way to help doctors in liver disease clinics better treat patients who have both alcohol use disorder (AUD) and alcohol-associated liver disease (ALD). The intervention, called "Implementation Intervention," includes educating doctors, providing patient education, offering clinical decision support, and giving doctors feedback on their care. The goal is to make it easier for patients to get medications and counseling for AUD, which can help reduce liver problems. This study is looking at whether this approach is practical and can be put into practice over 12 months. It aims to enroll 30 participants, who are healthcare providers at Yale School of Medicine and YNHH medical system who treat liver disease.

Study design

This interventional study is designed to test a behavioral intervention with an enrollment of 30 participants. The phase of the study is not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Feasibility will be measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.